EACR Cancer Genomics 2019 conference: from tumour evolution to personalised immunotherapy

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recent advances in cancer genomics are revolutionising our understanding of the genetic basis of tumour proliferation and of the impact of the immune system and microbiome in drug response. The 4th Cancer Genomics conference hosted by the European Association for Cancer Research covered breakthroughs in this field such as the search for novel cancer antigens and single-cell mapping of tumour evolution. This report focuses on the novel insights obtained from a variety of research groups under the banner of cancer genomics, as well as some insights of the general discussions held at the conference focussing on setting up a successful laboratory and possible alternatives in the scientific career.

Cite

CITATION STYLE

APA

Lanzós, A., & Elliott, K. (2019). EACR Cancer Genomics 2019 conference: from tumour evolution to personalised immunotherapy. In FEBS Journal (Vol. 286, pp. 4209–4214). Blackwell Publishing Ltd. https://doi.org/10.1111/febs.15063

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free